Title : Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010 - Zilkens_2014_Alzheimers.Dement_10_310 |
Author(s) : Zilkens RR , Duke J , Horner B , Semmens JB , Bruce DG |
Ref : Alzheimers Dement , 10 :310 , 2014 |
Abstract :
BACKGROUND: The Australian Pharmaceutical Benefits Scheme (PBS) first subsidized cholinesterase inhibitors (CEIs) for Alzheimer's disease in 2001, introducing a novel therapy for a previously untreatable common condition. This study aims to determine Australian rates of CEI use and to assess equality of access to treatment based on socioeconomic status and geographic remoteness. |
PubMedSearch : Zilkens_2014_Alzheimers.Dement_10_310 |
PubMedID: 23849590 |
Zilkens RR, Duke J, Horner B, Semmens JB, Bruce DG (2014)
Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010
Alzheimers Dement
10 :310
Zilkens RR, Duke J, Horner B, Semmens JB, Bruce DG (2014)
Alzheimers Dement
10 :310